Erratum: Oral doxycycline for the treatment of chronic leg ulceration (Archives of Dermatological Research DOI:10.1007/s00403-011-1201-5);Oral doxycycline for the treatment of chronic leg ulceration

Archives of Dermatological Research

Volumn 304, Issue 6, 2012, Pages 487-493

  Sadler, Genevieve M ^a   Wallace, Hilary J ^b   Stacey, Michael C ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Doxycycline; Leg ulcer; Matrix metalloproteases; Quantitative bacteriology; Tumour necrosis factor

Indexed keywords

DOXYCYCLINE; GELATINASE B; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; CHRONIC DISEASE; CLINICAL ARTICLE; COLONY FORMING UNIT; COMPRESSION BANDAGE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE DURATION; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; LEG ULCER; LOW DRUG DOSE; MALE; PILOT STUDY; PRIORITY JOURNAL; WOUND FLUID; WOUND HEALING;

EID: 84864741738     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1211-y     Document Type: Erratum

References (28)

1. Ashley RA (1999) Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. Ann N. Y. Acad Sci 878:335-346
2. Baker SR, Stacey MC (1994) Epidemiology of chronic leg ulcers in Australia. Aust N. Z. J Surg 64:258-261
3. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Poison AM, Thomas J, Walker C (2000) Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 71:521-532
4. Cazalis J, Bodet C, Gagnon G, Grenier D (2008) Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. J Periodontol 79:1762-1768
5. Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS (2003) Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 15:315-323
6. Ding R, McGuiness CL, Burnand KG, Sullivan E, Smith A (2005) Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline. Vascular 13:290-297
7. Gelfand JM, Hoffstad O, Margolis DJ (2002) Surrogate endpoints for the treatment of venous leg ulcers. J Invest Dermatol 119:1420-1425
8. Gliner JA, Morgan GA, Harmon RJ (2003) Pretest-Posttest comparison group designs: analysis and interpretation. J Am Acad Child Adolesc Psychiatry 42:500-503
9. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26
10. Joshi N, Miller DQ (1997) Doxycycline revisited. Arch Intern Med 157:1421-1428
11. Lindeman JH, Abdul-Hussien H, von Bockel H, Wolterbeek R, Kleemann R (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm. Circulation 119:2209-2216
12. Mackelfresh J, Soon S, Arbiser JL (2005) Combination therapy of doxycycline and topical tacrolimus for venous ulcers. Arch Dermatol 141:1476-1477
13. Mulivor AW, Lipowsky HH (2009) Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloproteinase activity with doxycycline. Microcirculation 16:657-666
14. Nordstrom D, Lindy O, Lauhio A, Sorsa T, Santavirta S, Konttinen YT (1998) Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumtol Int 17:175-180
15. Pascale D, Gordon J, Lamster I, Mann P, Seiger M, Arndt W (1986) Concentration of doxycycline in human gingival fluid. J Clin Periodontol 13:841-844
16. Phillips T, Stanton B, Provan A, Lew R (1994) A study of the impact of leg ulcers on quality of life: financial, social and psychological implications. J Am Acad Dermatol 31:49-53
17. Rayment EA, Upton Z, Shooter GK (2008) Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to severity of the ulcer. Br J Dermatol 158:951-961
18. Romero-Perez D, Fricovsky E, Yamasaki KG, Barraza-Hidalgo M, Dillmann W, Villarereal F (2008) Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection. J Am Coll Cardiol 52:1086-1094
19. Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge-Smith PD (1997) Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 26:265-273
20. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, Ohtani H, Andoh N, Takeha S, Konttinan YT (1994) Effects of tetracyclines on neutrophil, gingival and salivary collagenases. Ann N Y Acad Sci 732:112-131
21. Stechmiller J, Cowan L, Schultz G (2010) The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds. Biol Res Nurs 11:336-344
22. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S (1998) The pharmokinetic profile as a biodegradable controlledrelease delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva and serum. J Periodontal 69:1085-1091
23. Thomas J, Walker C, Bradshaw M (2000) Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 71:1472-1483
24. Trengove NJ, Bielfeldt-Ohmann H, Stacey MC (2000) Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Rep Regen 8:13-25
25. Trengove NJ, Langton SR, Stacey MC (1996) Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 4:234-239
26. Trengove NJ, Stacey MC, Macauley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Regen 7:442-452
27. Wallace HJ, Vandongen YK, Stacey MC (2006) Tumour necrosis factor alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol 126:921-925
28. Weckwoth M, Vaheri A, Sorsa T, Konttinen YT (1996) Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106:1119-1124